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ABSTRACT
The current clinical dogma assumes that urine is sterile in the absence of
clinically relevant infection. However, recent evidence has demonstrated the existence of
a female urinary microbiota in women with and without lower urinary tract symptoms.
With the knowledge that the lower urinary tract possesses its own unique microbiota, I
hypothesize that certain bacterial species of the female microbiota may be the cause or
play a role in lower urinary tract syndromes, such as overactive bladder syndrome
(OAB). About 40-50% of OAB patients do not respond to conventional anti-muscarinic
and beta-3 adrenergic agonist drug treatment. One possible explanation for this lack of
treatment response is a dysbiosis of urinary microbiota. To determine if women with
OAB have a dysbiotic urinary microbiota, our group developed an expanded quantitative
urine culture (EQUC) protocol to culture transurethral catheter urine specimens obtained
from women with and without OAB. EQUC revealed differences in the female urinary
microbiota in women with and without OAB. Given evidence of planktonic bacteria in
the urine, I hypothesized that bacteria also may be associated with the urothelium. To test
this hypothesis, I examined urothelial cells shed into urine for the presence of adherent
and/or intracellular bacteria. I used a new protocol that was able to determine which
bacteria associate with shed urothelial cells, but could not distinguish between adherent
or intracellular bacteria. By identifying differences in the urinary microbiota between
women with different disease/health states, and by determining which of those bacteria
vii

associate with the urothelium, one can begin to understand how the female urinary
microbiota

could

contribute

to

lower

viii

urinary

tract

disorders.

CHAPTER ONE
INTRODUCTION
Urinary health disorders affect many people. For example, overactive bladder
syndrome (OAB) affects about 15% of adult women with increasing incidence with age
(Hartmann et al., 2009). The exact etiology of OAB is not known, but one cause is
thought to be a neuro-muscular dysfunction; thus, the treatment options for OAB are the
administration of anti-muscarinic drugs or beta-3 adrenergic receptor agonists to relieve
the symptoms (Michel & Chapple, 2009). However, the side effects (such as severe dry
mouth or urinary retention) can be uncomfortable for the patient and only 50-60% of
patients have their symptoms resolved (Santos & Telo, 2010, Chapple et al., 2013). Since
anti-muscarinic and beta-3 adrenergic agonist treatments aimed at relaxing the bladder
are ineffective in a large percentage of OAB sufferers, it is likely that there are etiologies
outside of neuro-muscular dysfunction (Nitti et al., 2010).
Emerging DNA sequencing and culture evidence indicates that microbial
communities exist within the bladder (Siddiqui et al., 2011, Fouts et al., 2012, Nelson et
al., 2012, Wolfe et al., 2012, Khasriya et al., 2013, Lewis et al., 2013, Brubaker et al.,
2014, Hilt et al., 2014, Pearce et al., 2014). With this evidence that bacterial DNA
(microbiome) and live bacteria (microbiota) exist within the bladders of women with
OAB and of women without OAB, it is possible that microbes represent a new etiology
1
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or a contributing factor for OAB. For example, women who do not respond to OAB
therapies might not suffer from OAB; instead, a causative or contributing bacterium
might not be a known uropathogen or it might be present at lower colony forming units
(CFU)/mL than the threshold of 105 CFU/mL used in standard practice since the 1950s
(Kass, 1956, Kass, 1957). Alternatively, women who do not respond may have a
dysbiosis of their microbiota. How bacteria cause OAB symptoms is not known, but
bacteria present in the bladder could interact with the urothelium such that the detrusor
urinae muscle is induced to contract and initiate, exacerbate or propagate OAB
symptoms.
The overall hypothesis of this present study was that the female urinary
microbiota are different in women with and without OAB. The aims to address the
overall hypothesis of the present study were to: (1) isolate and identify the bacteria that
comprise the female urinary microbiota and (2) determine if the bacterial species of the
female urinary microbiota are associated with the human urothelium.

3
LITERATURE REVIEW
Female Lower Urinary Tract Biology
The lower urinary tract consists of the following anatomical sites: the ureters, the
bladder, and the urethra. In a female, the ureters connect the renal pelvis to the bladder,
which is then connected to the vulva by the urethra (Martini FH, 2009).
The ureters are muscular tubes that extend inferiorly from the renal pelvis and
penetrate the posterior wall of the bladder where urine is deposited. The bladder is a
hollow muscular organ that functions as a temporary storage unit for urine. When the
bladder is empty, it is decompressed; as the bladder fills with urine, it takes on a spherical
shape. The area of the bladder where the urethra attaches is known as the trigone. This
trigone acts as a funnel that channels urine through the urethra as the bladder contracts.
The urethra, which is about 3-5 cm in females, connects the neck of the bladder to the
vulva or exterior (Martini FH, 2009).
Each anatomical site has its own characteristic histology. The ureters consist of
three layers: an inner mucosa lining also known as urothelium, a muscular layer made up
of smooth muscle, and an outer connective tissue layer (Martini FH, 2009, Birder &
Andersson, 2013). The bladder also contains three layers. First, there is the mucosa layer,
comprised of the urothelium and the lamina propria (Martini FH, 2009, Birder &
Andersson, 2013). Next is the muscularis propria, which contains the detrusor urinae
muscle; when contracted, it compresses the bladder to expel the urine into the urethra
(Martini FH, 2009, Birder & Andersson, 2013). Finally there is the adventitia/serosa layer
composed of connective tissue (Martini FH, 2009, Birder & Andersson, 2013). At the
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junction of the bladder and urethra, there is a circular band of skeletal muscle known as
the urethral sphincter that remains in a relaxed muscle state until it is voluntarily
contracted to allow urination. The urethra is lined with a transitional epithelium and is
surrounded by layers of smooth muscle (Martini FH, 2009).
The detrusor urinae muscle can be stimulated by a variety of receptors by both the
parasympathetic and sympathetic nervous systems (Martini FH, 2009). Two types of
receptors are stimulated via the parasympathetic nervous system: the cholinergic nicotinic
and muscarinic receptors; both are stimulated by the neurotransmitter acetylcholine
(ACh), which induces an activation or contraction effect on the detrusor urinae muscle
(Martini FH, 2009). The type of receptor stimulated via the sympathetic nervous system
is the adrenergic beta-receptor. The adrenergic beta-receptor is stimulated by the
neurotransmitters epinephrine and norepinephrine and has an inhibitory or relaxation
effect on the detrusor urinae muscle (Martini FH, 2009, Goldenberg, 2012).
Recent evidence shows urothelial cells that comprise the urothelium can be
stimulated via the same receptors found on the detrusor urinae muscle. These receptors
include the adrenergic beta-receptors and the cholinergic nicotinic and muscarinic
receptors. Thus, urothelial cells can both be targets of these receptors’ neurotransmitters
and release various mediators to influence detrusor urinae muscle cell contraction (Birder
& Andersson, 2013).

5
History of Clinical Microbiology Urine Culture
The current clinical dogma assumes that urine is sterile in the absence of
clinically relevant infection. Since the 1950’s, the clinical practice for detecting infection
in the bladder, including urinary tract infection, cystitis and pyelonephritis, has been
based on a method that detects bacterial species present in mid-stream urine at greater
than or equal to 105 colony forming units (CFU)/mL (Kass, 1956, Kass, 1957). However,
this threshold of ≥105 CFU/mL was not designed to detect infection in the bladder.
Instead, it was originally set as a threshold to detect kidney infection or pyelonephritis
(Kass, 1956, Kass, 1957), which is characterized by chills, fever, flank pain and dysuria
(Beeson, 1955, Kass, 1956). In the 1950’s, Dr. Edward Kass, an infectious disease
physician, sought a method to prevent post-operative sepsis in patients undergoing kidney
surgery. To achieve his goal, he needed a reliable test that could detect uropathogens in
urine collected via a non-invasive procedure. He chose midstream urine and identified the
threshold of ≥105 CFU/mL as adequate for the task (Kass, 1956, Kass, 1957).
Yet, many studies have provided evidence that this threshold is insufficient to
detect significant infection of the lower urinary tract in all types of patient populations
(Stamm et al., 1982, Stark & Maki, 1984, Lipsky et al., 1987, Maskell, 2010, Hooton et
al., 2013, Khasriya et al., 2013). Dr. William Stamm (1982) demonstrated that 102 of a
known uropathogen in the midstream urine of women was indicative of lower urinary
tract infection (Stamm et al., 1982), while Dr. Benjamin Lipsky (1987) showed that a
threshold of 103 CFU/mL of a known uropathogen in midstream urine was indicative of
lower urinary tract infection in men (Lipsky et al., 1987). Similarly, Dr. Randall Stark
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(1984) determined that a bacterium present at lower than 10 CFU/mL was indicative of
lower urinary tract infection in catheterized patients (Stark & Maki, 1984).
At about the same time, Dr. Rosalind Maskell (1981-1988) performed
scientifically rigorous studies that provided compelling evidence to disprove the dogma
that urine was sterile in the absence of a clinically relevant infection (Maskell, 2010). In
one of her studies, Dr. Maskell collected supra-pubic aspirate (SPA) urine specimens
from women suffering from a whole host of lower urinary tract disorders, including
dysuria and interstitial cystitis (Maskell, 2010). She then plated the SPA samples and
incubated the plates in different conditions for a longer period. She explained:
“Overnight incubation in air of cultures on a primary isolation medium
does not detect organisms other than the aerobic pathogens. Many
organisms with other requirements, for example anaerobes and CO2requiring bacteria and those species that need longer incubation, are
well recognised as pathogens in sites other than the urinary tract
(Maskell, 2010)”
Dr. Maskell showed the presence of bacteria in these SPA samples and hypothesized that
other bacterial species are likely present in the urinary tract. She further hypothesized that
it is either a dysbiosis of commensal flora and/or an unknown uropathogen that is causing
these women to suffer from lower urinary tract disorders other than a urinary tract
infection (UTI) (Maskell, 2010).
Dr. Maskell was not the only one to hypothesize that bacteria may influence
symptoms in lower urinary tract disorders. Dr. Thomas Hooton and colleagues (2013)
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obtained transurethral catheter (TUC) specimens from women suffering from cystisis
and found evidence of many Gram-positive bacteria, such as lactobacilli, staphylococci,
streptococci and Gardnerella vaginalis (Hooton et al., 2013). Hooton and colleagues did
not go into detail about whether these Gram-positive bacteria are a consequence or a
cause of cystitis, but they did suggest a re-evaluation of the use of midstream urine
cultures to make an accurate diagnosis of a patient with lower urinary tract symptoms and
to consider the idea the bladder possesses a resident bacteria flora (Hooton et al., 2013).

Overactive Bladder Syndrome
Urinary health disorders affect many people. For example, overactive bladder
syndrome (OAB) affects about 15% of adult women with increasing incidence with age
(Hartmann et al., 2009). OAB is characterized by symptoms of urinary urgency, often
with frequency and urgency incontinence, nocturia and a negative standard urine culture
(Haylen et al., 2010).
The exact etiology of OAB is not known, but one cause is thought to be a
neurological disorder due to increased release of the neurotransmitter ACh, which binds
to cholinergic nicotinic and cholinergic muscarinic receptors on the detrusor urinae
muscle and causes contractions and the feeling of urgency (Martini FH, 2009, Michel &
Chapple, 2009).
One treatment for OAB is the administration of anti-muscarinic drugs (e.g.,
Solifenacin) to prevent the binding of ACh to the cholinergic muscarinic receptor and
therefore relieve the symptoms (Michel & Chapple, 2009, Nitti et al., 2010). However,
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uncomfortable side effects (such as severe dry mouth) are causes for reduced
compliance. Furthermore, only 50-60% of patients have their symptoms resolved
(responders), while 40-50% of patients retain symptoms (non-responders) (Santos &
Telo, 2010).
Another more recent treatment option for OAB is the administration of a beta-3
adrenergic receptor agonist known as Mirabegron. This agonist binds to beta-3 adrenergic
receptors and causes the detrusor muscle to relax (Goldenberg, 2012, Afeli et al., 2013).
This relaxation of the detrusor muscle counteracts the overstimulation of cholinergic
muscarinic receptors. However, a major side effect with Mirabegron is urinary retention
due to too much relaxation of the detrusor muscle (Goldenberg, 2012). Moreover, the
response rate to Mirabegron is similar to that of Solifenacin (Chapple et al., 2013,
Abrams et al., 2014).
Since both anti-muscarinic and beta-3 adrenergic agonist treatments aimed at
relaxing the bladder are ineffective in a large percentage of OAB sufferers, it is likely that
there are etiologies and/or causes outside of neuro-muscular dysfunction (Nitti et al.,
2010).

The Female Urinary Microbiome/Microbiota
Recent DNA sequencing and culture evidence reveals the presence of microbial
communities within the bladder (Siddiqui et al., 2011, Fouts et al., 2012, Nelson et al.,
2012, Wolfe et al., 2012, Khasriya et al., 2013, Lewis et al., 2013, Brubaker et al., 2014,
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Hilt et al., 2014, Pearce et al., 2014). These data demonstrate the existence of the
urinary microbiome (bacterial DNA) and the urinary microbiota (live bacteria).
Various investigators have used culture-independent 16S rRNA gene sequencing
to acquire evidence of diverse bacteria that are not routinely cultured by clinical
microbiology laboratories in the mid-stream urine of women and men (Nelson et al.,
2010, Dong et al., 2011, Siddiqui et al., 2011, Nelson et al., 2012).
Wolfe and co-workers (2012) went a step further, providing definitive evidence of
bacterial DNA in the bladders of women. They used 16S rRNA gene sequencing to
identify bacterial DNA present in ‘culture-negative’ urine specimens collected from
women diagnosed with pelvic organ prolapse and/or urinary incontinence and from
women without urinary symptoms. In this study, urine was collected via three methods:
clean, catch midstream voided (MV), transurethral catheter (TUC) and suprapubic
aspirate (SPA). The bacterial DNA communities detected in paired TUC and SPA
samples were similar, while the MV samples contained a mixture of urinary and genital
tract bacterial communities. Because the SPA samples were obtained directly from the
bladder, these researchers concluded that urine in the bladder contained bacterial DNA.
Since the SPA and TUC samples were similar, they concluded that TUC samples were
representative of bacterial communities present in the bladder (Wolfe et al., 2012).

Intracellular Bacteria and Urothelium
Many bacterial species reported to cause UTI colonize the urinary tract. The only
way to successfully colonize is to associate with the urothelium. A key step in
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pathogenesis for major uropathogens, such as Proteus mirabilis, Klebsiella
pneumoniae, and Escherichica coli, is their association with the urothelium (Coker et al.,
2000, Struve et al., 2008, Hunstad & Justice, 2010). In the case of Klebsiella pneumoniae
and Escherichia coli, they both express type 1 fimbriae that attach to urothelial cell
receptors; this allows them to be taken up intracellularly (Struve et al., 2008, Hunstad &
Justice, 2010). Proteus mirabilus expresses many types of fimbriae, which permits it to
attach to diverse urothelial cell receptors (Pearson et al., 2008). Other bacterial species
shown to associate with the urothelium and reported to cause a UTI include
Streptococcus agalactiae or Group B Streptococcus (GBS) and Enterococcus faecalis
(Ulett et al., 2010, Horsley et al., 2013).
Bacterial species that associate with the urothelium are of interest because they
are likely to play a role in lower urinary tract disorders such as OAB. With evidence of a
urinary microbiota (Hilt et al., 2014) and evidence that certain bacterial species associate
with shed uroepithelial cells in the urine (Horsley et al., 2013, Khasriya et al., 2013), it is
reasonable to hypothesize that some of these bacteria associate with the urothelium and
that these associations may play a role in lower urinary tract disorders.

CHAPTER TWO
METHODS AND MATERIALS
Patients and Sample Collection: Following Loyola institutional review board (IRB)
approval for all phases of this project, participants gave verbal and written consent for the
collection and analysis of their urine for research purposes. Participants were women
undergoing OAB treatment and a comparison group of women undergoing benign
gynecologic surgery (controls). Participants' symptoms were characterized with the
Pelvic Floor Distress Inventory (PFDI), a self-completed, validated symptom
questionnaire (Barber et al., 2006). All participants were without clinical evidence of
urinary tract infection (i.e., standard urine culture negative and absence of clinical UTI
diagnosis). Urine was collected via transurethral catheter from participants for the period
March 2013 to April 2014 at the Female Pelvic Medicine and Reconstructive Surgery
center of Loyola University Medical Center. A portion of each urine sample was placed
in a BD Vacutainer Plus C&S Preservative Tube (Becton Dickinson and Co; Franklin
Lakes, NJ)	
   and sent to the clinical microbiology lab for quantitative culture. A separate
portion of the urine sample, to be used for sequencing, was placed at 4°C for no more
than 4 h following collection. To this portion, 10% AssayAssure (Thermo Scientific;
Waltham, MA)	
  was added before freezing at −80°C.
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Standard Urine Culture: The clinical microbiology laboratory staff processed each
catheterized urine sample using the standard culture procedure. Standard urine culture
was performed by inoculating 0.001 ml of urine onto a 5% sheep blood agar plate (BAP)
and MacConkey agars (BD BBL™ Prepared Plated Media, Becton Dickinson and 94 Co;
Sparks, MD) and streaking the entire plate surface to obtain quantitative colony counts.
The plates were incubated aerobically at 35°C for 24 h (Figure 1). Each separate
morphological colony type was counted and identified in any amount. The detection level
was 103 CFU/ml, represented by 1 colony of growth on either plate. If no growth was
observed, the culture was reported as “no growth” (of bacteria at lowest dilution, i.e.,
1:1000).
Expanded Quantitative Urine Culture (EQUC): Each catheterized urine sample also was
processed using the EQUC procedure (Hilt et al., 2014). For EQUC, 0.1 ml of urine was
inoculated onto BAP, chocolate and colistin, and nalidixic acid (CNA) agars (BD BBL™
Prepared Plated Media), streaked for quantitation, and incubated in 5% CO2 at 35°C for
48 h. A second set of BAPs, were each inoculated with 0.1 ml of urine and incubated in
room atmosphere at 35°C and 30°C for 48 h. Next, 0.1 ml of urine was inoculated onto
each of two CDC anaerobe 5% sheep blood agar plates (BD BBL™ Prepared Plated
Media) and incubated in either a Campy gas mixture (5% O2, 10% CO2, 85% N) or under
anaerobic conditions at 35°C for 48 h. The detection level was 10 CFU/ml, represented
by 1 colony of growth on any of the plates. Finally, to detect any bacterial species that
may be present at quantities lower than 10 CFU/ml, 1.0 ml of urine was placed in
thioglycolate medium (BD BBL™ Prepared Tubed Media) and incubated aerobically at
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Figure 1-Outline of Standard Urine and Expanded Quantitative Urine Culture
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35°C for 5 days. If growth was visually detected in the thioglycolate medium, the
medium was mixed and a few drops were plated on BAP and CDC anaerobe 5% sheep
blood agars for isolation and incubated aerobically and anaerobically at 35°C for 48 h
(Figure 1). Each morphologically distinct colony type was isolated on a different plate of
the same media to prepare a pure culture that was used for identification. Because no
unique bacterial species were detected in three of the EQUC conditions (Campy Gas
mixture-5% O2, 10% CO2, 85% N at 37°C for 48 hours, Aerobic at 30°C for 5 days, and
Thioglycolate medium Aerobic for 5 days), I removed those conditions from the EQUC
protocol as of December 2013
Identification of Pure Isolates: Matrix assisted laser desorption ionization–time of flight
mass spectrometry (MALDI-TOF MS) was used to identify each morphologically distinct
colony. The direct colony method was performed. Using toothpicks, we applied a small
portion of a single isolated colony to the surface of a 96-spot, polished, stainless steel
target plate (Bruker Daltonik GmbH, Leipzig, Germany) in a manner that created a thin
bacterial film. The spot was left to dry at room temperature for 1 min., whereupon 1.0 µl
of 70% formic acid was applied to each sample and allowed to dry at room temperature
for 10 min. Then, 1.0 µl of the matrix solution, comprised of saturated α-cyano-4hydrocinnamic acid (Bruker Daltonik) in an organic solvent (High-Pressure Liquid
Chromatography-Mass Spectrometry [HPLC-MS]-grade water, 100% Trifluoroacetic
Acid, and Acetonitrile; Fluka) was then applied to each sample and allowed to
cocrystallize at room temperature for 10 min. The prepared sample target was placed in
the MicroFlex LT mass spectrometer (Bruker Daltonik), and the results were analyzed by
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MALDI Biotyper 3.0 software (Bruker Daltonik). A bacterial quality control strain
(Escherichia coli DH5α) was included in each analysis. A single measurement was
performed once for each culture isolate.
MALDI Data Analyses: MALDI Biotyper 3.0 software Realtime Classification was used
to analyze the samples. In the Realtime Classification program, log score identification
criteria are used as follows. A score between 2.000 and 3.000 is species-level
identification, a score between 1.700 and 1.999 is genus-level identification, and a score
that is below 1.700 is an unreliable identification. A Realtime Classification log score
was given for each bacterial isolate sample for every condition from which it was
isolated.
DNA Isolation, PCR Amplification and 16S rRNA Amplicon Sequencing: Genomic
DNA was extracted from urine using previously validated protocols (Wolfe et al., 2012,
Yuan et al., 2012). Briefly, 1 ml of urine was centrifuged at 13,500 rpm for 10 min and
the resulting pellet was resuspended in 200 µl of filter-sterilized buffer consisting of 20
mM Tris-Cl (pH 8), 2 mM Ethylenediaminetetraacetic Acid (EDTA), 1.2% Triton X-100,
and 20 µg/ml lysozyme and supplemented with 30 µl of filter-sterilized mutanolysin
(5,000 U/ml, Sigma-Aldrich; St. Louis, MO). The mixture was incubated for 1 h at 37°C
and the lysates were processed through the DNeasy blood and tissue kit (Qiagen,
Valencia, CA) according to the manufacturer's protocol. The DNA was eluted into 50 µl
of AE buffer (pH 8.0) and stored at −20°C. The variable region 4 (V4) of the bacterial
16S rRNA gene in each DNA sample was amplified and sequenced using a custom
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protocol developed for the MiSeq desktop sequencer (Illumina; San Diego, CA).
Briefly, the 16S rRNA V4 region was amplified in a two-step nested polymerase-chain
reaction (PCR) protocol using the universal 515F and 806R primers, which were
modified to contain the Illumina adapter sequences. Amplicons were analyzed by gel
electrophoresis and purified using the QIAquick gel extraction kit (Qiagen). Extractionand PCR-negative controls were included in all steps to assess potential DNA
contamination. DNA samples were diluted to 10 nM, pooled, and sequenced using the
MiSeq personal sequencer platform using a paired-end 2× 251-bp reagent cartridge. Raw
sequences were processed using the open-source program mothur, v1.31.2 (Kozich et al.,
2013). Paired ends were joined and contigs of incorrect length (<285 bp or >300 bp)
and/or contigs that contained ambiguous bases were removed. Sequences were aligned
using the SILVA database, and chimeric sequences were removed with UCHIME (Edgar
et al., 2011). Sequences were classified using a naive Bayesian classifier and the RDP
16S rRNA gene training set (v9). Sequences that could not be classified to the bacterial
genus level were removed from analysis.
Statistical Analyses: Statistical analyses of the microbiota data were performed using
SAS software version 9.3. The frequency of detected genera and species was compared
between groups (OAB v Control), using either Pearson chi-square or Fisher’s exact tests,
depending on assumption validity. The Wilcoxon rank sum tests were used to compare
the median abundance for the cultured genera between groups. No adjustments for
multiple comparisons were made since these analyses were considered descriptive.
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Filtered Urine Culture: Each urine specimen (10 mL) was placed through a filtration
system (Figure 2). The first 5 mL of urine was filtered through a Nucleopore filter with a
pore size 5.0 µm (Whatman). To ensure that free bacteria pass through the filter, a 5.0mL
phosphate buffered saline (PBS) wash was performed. The 5.0 µm filter, which captured
the urothelial cells (20 -100 µm) (Croft et al., 1979, Bostwick & Cheng, 2008), was
placed on a blood plate and incubated in a 5% CO2 incubator at 37°C for 48 hours. The
filtrate, containing planktonic bacteria, was subjected to the EQUC protocol (above in
Materials and Methods). All colonies were counted and any morphologically distinct
colony was isolated onto a fresh plate composed of the same medium to prepare a pure
culture to be used for identification with MALDI-TOF MS. The second 5 mL of urine
was filtered through a Nucleopore filter with a pore size of 0.2 µm, as described above.
All bacteria and urothelial cells were captured on the filter (Hobbie et al., 1977,
Bernhardt et al., 1991). The filter and filtrate from the 0.2 µm arm were handled as
described above.
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Figure 2- Outline of Filtered Urine Culture Protocol
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Antibiotic Protection Assay: As a control, the EQUC protocol was performed on the
urine samples (as described in Aim 1) to identify the bacterial species present without
treatment. The urine sample (50 mL) was centrifuged at 400 x g at room temperature for
10 minutes. The supernatant was removed and the pellet was washed in 1.0 mL of PBS.
The 1.0 mL of solution was split into two 0.5mL solutions and centrifuged at the same
speed and time. Then, each pellet was re-suspended in either 1.0 mL of PBS or 1.0 mL of
an antibiotic cocktail (200 ug/mL Gentamicin, 100 units/mL Penicillin, 100 mg/mL
Streptomycin) in PBS and then let sit for 2 hours to kill any planktonic or adherent
bacteria. The 1.0 mL solution for each condition was split into two 0.5 mL solutions and
centrifuged at the same speed and time. Then, the pellets either were re-suspended in 1.0
mL of PBS or 1.0 mL of 0.1% Triton-X-100 in PBS and let sit for 5 minutes to lyse the
cells. This procedure resulted in a total of four conditions (PBS-PBS, PBS-Triton X,
Antibiotics-PBS, Antibiotics-Triton X); all four were subjected to the EQUC protocol
(Figure 3). All colonies were counted and any morphologically distinct colony was
isolated onto a fresh plate composed of the same medium to prepare a pure culture for
identification with MALDI-TOF MS
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Figure 3- Outline of Antibiotic Protection Assay	
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Human Urothelial Cell/UPEC Infection Assay: An infection assay with an
immortalized human urothelial cell line infected with uropathogenic Escherichia coli
(UPEC) was performed and then subjected to the antibiotic protection assay as a proof of
principle (Figure 4). The infection assay with the immortalized human urothelial cell line
was designed and optimized by Dr. Meghan Pearce. Dr. Phong Lee established the
immortalized human urothelial cell line from a female non-malignant bladder. Four days
prior to infection of urothelial cells, strains of UPEC were streaked onto Lysogeny Broth
(LB) agar and incubated overnight at 37°C. Then a single colony of UPEC strain of
interest was inoculated into 5 mL of liquid LB and incubated overnight at 37°C shaking.
Next, a subculture of 1:1000 of the UPEC into fresh liquid LB was done and allowed to
incubate at 37°C overnight with no shaking. The day before infection, this subculture
process was repeated. To prepare the human urothelial cells, the day before infection,
cells were counted with a hemocytometer and then diluted to 1x105 cells/mL in tissue
culture media. In triplicate, 1 mL aliquots of urothelial cells were placed into a 24-well
tissue culture treated plate and incubated overnight at 37°C in 5% CO2 to allow the cells
to adhere to the well. The day of infection, the human urothelial cells were examined to
see that they had adhered to the wells. The old media was aspirated out and the cells were
washed 3 times with 1 mL PBS. Then 1.0 mL of Dulbecco’s Modified Eagle Medium:
Nutrient Mixture F-12 (DMEM/F-12)/5% Fetal Bovine Serum (FBS) was added to each
well and allowed to incubate for 30min. To obtain a rough estimate of the multiplicity of
infection (MOI) for UPEC, one well of urothelial cells was trypsinized and the number of
cells
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Figure 4- Outline of Human Urothelial Cell/UPEC Infection Assay
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counted. The UPEC culture was either diluted or concentration to so that there would
be 10 UPEC cells for every 1 urothelial cell. Once this UPEC MOI of 10 was prepared,
1.0 mL of this inoculum was added to each of three wells containing urothelial cells. As a
negative control, one well of cells was not inoculated with UPEC. The 24-well plate with
cells was centrifuged at 1400 rpm for 5 min to initiate contact of the UPEC with the
urothelial cells. The plate was incubated at 37°C in 5% CO2 for 2 hours. Once the 2-hour
infection was completed, the cells in each well were trypsinized (1 uninfected well and 3
infected wells) and run separately through the Antibiotic Protection Assay. As a control,
to determine the average intracellular count per well, the infection assay was continued.
First, the human urothelial cells and UPEC were treated for 2 hours with the same
antibiotic cocktail used in the antibiotic protection assay (200 ug/mL Gentamicin, 100
units/mL Penicillin, 100 mg/mL Streptomycin). Second, the cells were washed 3 times
with 1.0 mL of PBS and then treated with 1.0 mL of 0.1% Triton-X-100 in PBS and let
sit for 5 minutes to lyse the cells. Finally, each well was plated with serial dilutions onto
LB agar plates to determine the average intracellular count per well.

Tissue-Culture Adherence: The following protocol was designed and optimized by Dr.
Meghan Pearce (Figure 5). Each urine sample (20 mL) was centrifuged at 400 x g for 10
minutes. The resultant pellet was then re-suspended in tissue culture media and split into
microtiter plate wells with or without antibiotics (200 ug/mL Gentamicin, 100 units/mL
Penicillin, 100 mg/mL Streptomycin). The plate was then placed in a 5% CO2-enriched
incubator at 37°C for overnight incubation. Observations of human cells, cell debris, and
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Figure 5- Outline of Tissue Culture Adherence Assay
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bacteria in the wells were observed the next day. Then, the wells were subjected to a
gentle PBS wash to identify human urothelial cells that remain adherent to the plastic.
Following the wash, 0.5 mL of 0.1% Triton-X-100 was added to the cells for five minutes
to lyse the urothelial cells and the mixture centrifuged at 13,500 rpm for 10 minutes. This
resultant pellet was re-suspended in PBS and plated on a blood agar plate. This blood
agar plate was then be placed in a 5% CO2 incubator at 37°C for 48 hours. All colonies
were counted and any morphologically distinct colony was isolated onto a fresh plate
composed of the same medium to prepare a pure culture to be used for identification with
MALDI-TOF MS.

Antibiotic Sensitivities of Bacterial Isolates: For the bacterial isolates that appeared to
be intracellular, a control experiment for antibiotic sensitivity was performed. The
bacterial isolates were tested for sensitivity to the antibiotics used in the cocktail (200
ug/mL Gentamicin, 100 units/mL Penicillin, 100 mg/mL Streptomycin).

Culture of Bladder Biopsy: Following Loyola institutional review board (IRB) approval
for all phases of this project, participants gave verbal and written consent for the
collection and analysis of their urine and tissue for research purposes. The following
samples were collected from participants: transurethral catheter (TUC) urine, suprapubic
aspirate (SPA) urine and two small tissue biopsies of the bladder urothelium. EQUC was
performed on the TUC and SPA urine samples (as described in Aim 1) to identify the
bacterial species present. The tissue biopsies were washed twice with 1.0 mL of saline.
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After the second wash, each tissue biopsy was ground with a sterile mortar and pestle
in 1.0 mL of saline. Then 100 µL of the saline mixture was subjected to the EQUC
protocol.

CHAPTER THREE
ISOLATION AND IDENTIFICATION OF BACTERIA THAT COMPRISE THE
FEMALE URINARY MICROBIOTA
INTRODUCTION
16S rRNA gene sequence analysis of urine specimens has revealed the existence
of bacterial DNA in urine obtained from women diagnosed with pelvic organ prolapse
and/or urinary incontinence, as well as from women without urinary symptoms or
prolapse. Thus, a female urinary microbiome exists (Wolfe et al., 2012).
In addition, others and we have shown that these bacterial sequences represent
live bacteria; therefore, female urinary microbiota exist (Khasriya et al., 2013, Hilt et al.,
2014). These urinary microbiota were detected using expanded versions of the standard
urine culture. Specifically our group developed and performed an expanded quantitative
urine culture (EQUC) on TUC urines to culture bacterial genera detected by 16S rRNA
gene sequencing in previous studies. The bacterial genera being cultured matched the
previous sequencing data demonstrating the presence of a urinary microbiota (Hilt et al.,
2014).
With the existence of female urinary microbiota, one needs to determine if they
play a role in lower urinary tract disorders such as OAB. One diagnostic criterion for
OAB is a negative test for UTI - typically a standard urine culture. This culture is when
one inoculates 0.001 mL of urine to blood and MacConkey agar plates and then incubates
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aerobically at 35°C for 24 hours. This standard technique is geared toward detecting
known uropathogens at. the 105 CFU/mL threshold, consistent with the 1950’s intent of
Dr. Kass. Since the previous 16S rRNA sequencing and recent culture data of urine both
demonstrate the presence of bacteria that may not be known uropathogens and/or are
present at levels lower than the threshold, an expanded urine culture technique is needed
to fully assess the differences in the female urinary microbiota of women with and
without OAB.
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RESULTS
Standard Urine Culture vs. Expanded Quantitative Urine Culture (EQUC)
A total of 189 transurethral catheter urine specimens were collected from 61
women with OAB and 52 women without OAB. All urine specimens were processed
through standard and expanded quantitative urine culture (EQUC) techniques.
Most (153/189) urine specimens grew bacterial species with the EQUC approach.
Yet, 139 of the 153 urine specimens that grew bacterial species were deemed ‘No
Growth’ (Table 1) of bacteria at the lowest dilution, i.e., 1:1000) by the clinical
microbiology lab. These data demonstrate that bacterial species are present in ‘culturenegative’ urines and the standard urine culture has a false-negative rate of ~90%. One
specimen in particular demonstrates the value of the expanded quantitative culture
(Figure 6). To date, a total of 608 bacterial isolates that make up 116 diverse bacterial
species have been isolated from these urine specimens (Table 1). The median number of
different bacterial species per urine specimen was three (Table 1).
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Table 1- Summary of Urine Specimens
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Figure 6- 4-Week OAB Patient Urine. Urine specimen subjected to: (A) Standard
Culture Blood plate incubated 72 hours at 35°C. This routine plate was finalized as ‘No
Growth’ (of bacteria at the lowest dilution of 1:1000) at 24 hours. (B) Expanded Culture
Blood plate incubated 72 hours at 35°C.
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Female Urinary Microbiota in Baseline Urine Specimens in Women with and
without OAB. 	
  
A subset of 104 baseline urine specimens were subjected to the standard and
expanded quantitative urine cultures, 52 from women without OAB (Control) and 52
from women with OAB. 33 of the 52 (63.46%) control baseline specimens grew bacterial
species, while 45 of the 52 (86.54%) OAB baseline specimens grew bacterial species.
Overall the OAB baseline urine specimens had a greater number of bacterial
isolates than the control baseline urine specimens. Only 82 bacterial isolates were
isolated from the control specimens, whereas 261 bacterial isolates were isolated from the
OAB specimens (p= <0.0001). The median number of different bacterial species isolated
per control urine specimen was one [Interquartile Range (IQR)=0-2)], while the median
number of different bacterial species isolated per OAB urine specimen was four (IQR=17).
My results show that the OAB female urinary microbiota is richer than the control
female urinary microbiota. To date, 35 unique bacterial species make up the microbiota
of the controls, while 80 unique bacterial species comprise the microbiota of the
symptomatic OAB patients (Figure 7).
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Figure 7- Rarefaction Analysis of Unique Bacterial Species. Each unique bacterial
species isolated is documented in each patient cohort as patients are recruited. (OAB
N=52, Control N=52). 35 unique bacterial species comprise the control female urinary
microbiota, while 80 unique bacterial species comprise the OAB female urinary
microbiota.
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Statistical Analyses of Baseline Urine Cultures of Women with and without OAB.
The Pearson chi-square or Fisher’s exact tests were performed on the subset of
104 baseline urine specimens to determine differences in frequency of the genera and
species isolated in each cohort.
Seven

bacterial

genera

(Actinobaculum,

Actinomyces,

Aerococcus,

Corynebacterium, Gardnerella, Oligella and Streptococcus) were isolated more
frequently in the OAB cohort compared to the control cohort (Figure 8, Table 2). Three
of these bacterial genera were solely isolated from the OAB cohort (Actinobaculum,
Aerococcus, and Oligella); concentrations ranged from 10 CFU/mL to 100,000 CFU/mL.
The following bacterial species were isolated more frequently in OAB urine
specimens than from control urine specimens: Actinobaculum schaalii, Aerococcus
urinae, Corynebacterium coyleae, Corynebacterium riegelii, Gardnerella vagnialis,
Lactobacillus gasseri, Oligella urethralis, and Streptococcus anginosus (Figure 9, Table
2). The bacterial species Lactobacillus crispatus was isolated more frequently in the
control urine specimens than the OAB urine specimens (Figure 9, Table 2).
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Figure 8- Frequency of Bacterial Genera in Each Cohort. Comparison of the
percentage a given bacterial genus was isolated in either an OAB urine specimen (black
bars, N=52 urine specimens) or a control urine specimen (white bars, N=52 urine
specimens). Pearson’s Chi-square and Fisher’s Exact Test were performed to determine
statistically significant differences in isolated bacterial genera (* >0.05, **>0.001).
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Figure 9- Frequency of Bacterial Species in Each Cohort. Percentage a given bacterial
species was isolated in either an OAB urine specimen (black bars, N=52 urine specimens)
or a control urine specimen (white bars, N=52 urine specimens). Pearson’s Chi-square
and Fisher’s Exact Test were performed to determine statistically significantly
differences in isolated bacterial species (* >0.05, **>0.001).
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Table 2- P-values of Significant Bacterial Genera and Species

The whole number value represents the number of urine specimens in each cohort from
which a given bacterial genus/species was cultured. The (%) is the percentage of the total
urine specimens in each cohort from which a given bacterial genus/species was cultured.
The p-value is the significant value for the Fischer’s Exact Test. The * designates
significance reached for the Pearson Chi-Square Test.
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Comparison of Urine Culture and 16S rRNA Sequencing Data.
A subset of the baseline urine specimens subjected to EQUC (29% 30/105) was
also examined by 16S rRNA sequencing. In each of these 30 urine specimens, bacterial
DNA was detected; therefore, they were sequenced. Dr. Meghan Pearce performed all the
sequencing preparation and analyses.
Extensive overlap was observed in terms of the bacterial genera detected with
both sequencing and EQUC (Figure 10). A total of 18 different genera were cultured
with EQUC; all but Trueperella were detected by sequencing. These data provide
additional evidence that the sequenced genera of the urinary microbiome represent live
bacteria that make up the urinary microbiota.
In some urine specimens, EQUC detected genera not detected by sequencing
(Figure 10). Yet, these genera were sequenced in other urine specimens inferring that
they can be amplified with the universal primers used for sequencing. In these particular
urines, the genera detected by EQUC were in CFU concentrations lower than that which
could be detected by sequencing (101-103).
Five genera (Atopobium, Prevotella, Rhodanobacter, Sneathia, and Veillonella)
were only detected by sequencing (Figure 10). These data suggest that EQUC is limited
in its ability to detect these organisms.
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Figure 10- Comparison of Bacterial Genera Detected by EQUC and 16S rRNA
Sequencing. A comparison of the bacterial genera detected by sequencing and culture of
urine specimens (N=30). Each square was color-coded based on whether the bacterial
genera were detected by sequence only (green), EQUC only (red), sequence and EQUC
(yellow) or neither sequence nor EQUC (grey).
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ASSOCIATION OF BACTERIAL SPECIES OF THE FEMALE URINARY
MICROBIOTA WITH THE HUMAN UROTHELIUM
INTRODUCTION
Recent evidence demonstrates the existence of urinary microbiota (Hilt et al.,
2014, Pearce et al., 2014). Thus, live bacteria are present in the bladder, but it is not clear
if the bacteria associate with the bladder urothelium. Bacterial species that associate with
the urothelium are of interest because they are more likely to play a role in OAB
symptoms.
Previous studies have shown many uropathogens can attach to and invade
urothelial cells (Coker et al., 2000, Struve et al., 2008, Hunstad & Justice, 2010);
therefore, it is reasonable to hypothesize that some other urinary bacteria do likewise.
This hypothesis is supported by evidence that bacterial species obtained from standard
culture negative patients with lower urinary tract symptoms are closely associated to
urothelial cells (Horsley et al., 2013, Khasriya et al., 2013).
There are two methods one could use in order to identify bacterial species of the
urinary microbiota that associate with the urothelium. The first is to culture bladder
biopsy tissue. The second method to is to examine bacterial communities associating with
shed urothelial cells in urine (Horsley et al., 2013, Khasriya et al., 2013).
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In the latter experiment, a protocol was developed to optimize the second
method for future study use and to avoid the invasive procedure of a bladder biopsy to
distinguish between the bacterial populations (planktonic, adherent, intracellular) of the
urinary microbiota. The protocol combined three different assays to get an accurate
picture of the different bacterial populations in the urinary microbiota. These three assays
or arms of the protocol are the filtered urine culture (Figure 2), an antibiotic protection
assay (Figure 3) and a tissue-culture adherence assay (Figure 5).
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RESULTS
Bacterial Species of the Female Urinary Microbiota and Association with Bladder
Biopsy Tissue.
Four sets of bladder biopsies and urines (TUC and SPA) were obtained from
patients undergoing surgery at the Female Pelvic Medicine and Reconstructive Surgery
center of Loyola University Medical Center. All four patient’s urine and biopsy samples
were cultured using EQUC.
Three of the four patients did not have any growth in all the conditions (Table 3).
In contrast, bacteria were cultured from the urines and biopsies of one patient (010)
(Table 3). The TUC and SPA urine specimens contained significant and matching counts
of Klebsiella pneumoniae and Staphylococcus aureus. Both organisms were isolated from
the bladder biopsies, but in lower counts. The bladder biopsies of Patient 010 also grew
additional organisms (Lactobacillus gasseri, Enterococcus faecalis, and Enterococcus
faecium) that were not found in the TUC and SPA samples. The failure to detect these
organisms in the TUC and SPA samples may be due to low CFUs that cannot be detected
with EQUC, and/or the fact that both K. pneumoniae and S. aureus overgrew the plates.
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Table 3- Bladder Biopsy Tissue Culture Results
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Antibiotic Protection Assay’s Ability to Distinguish Between Populations of
Female Urinary Microbiota and their Associations with Urothelial Cells.
To distinguish between bacteria that associate with shed urothelial cells and
planktonic bacteria, we adapted a previously published antibiotic protection assay
(Khasriya et al., 2013) (Figure 3). This assay also should distinguish between bacteria
associated with the urothelial cells into subpopulations of bacteria that adhere to the cell
surface (PBS arms) and the bacteria that are intracellular (lysed arms) (Figure 3).
A total of 10 practice urine specimens collected via transurethral catheter were
used to optimize this Antibiotic Protection Assay arm (Table 4). These practice urines
were leftover urine specimens destined to be discarded after clinical evaluation of
patients at the Female Pelvic Medicine and Reconstructive Surgery center of Loyola
University Medical Center.
Four of the 10 practice urines (#7, 8, 12, 16) had ‘No Growth’ in any of the
conditions. However, bacteria were cultured from the other six practice urines and the
assay was able to distinguish between the bacterial species that were planktonic and those
that associated with shed urothelial cells. For example in both practice urines 10 and 11,
106 CFU of Escherichia coli was detected in the EQUC control. Once the urine was
placed through the assay and concentrated, there were 5 and 10 CFU/mL of Escherichia
coli, respectively, suggesting that a large amount of the Escherichia coli in these urine
specimens was planktonic while a small subset associated with the urothelial cells.
Practice Urine 9 (Table 4) had ‘No Growth’ in the control EQUC arm, but
Escherichia coli was detected in low CFU’s once the urine specimen was concentrated
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(PBS-treated). Thus, bacteria can be present in lower CFU counts than the thresholds
for the standard urine culture approach and even the EQUC protocol.
Practice Urine 15 (Table 4) had the same amount of Klebsiella pneumoniae and
Enterococcus faecalis in all three arms of the experiment. Since both organisms were
cultured in the antibiotic-treated arm, antibiotic sensitivities were performed on both
organisms. The Klebsiella pneumoniae and Enterococcus faecalis were both resistant to
the antibiotic cocktail (200 ug/mL Gentamicin, 100 units/mL Penicillin, 100 mg/mL
Streptomycin). This resistance was most likely acquired naturally within the patient or
was present in the bacteria before entering the patient. The resistance exhibited by these
organisms demonstrates the limit of this assay. In this urine, we are unable to distinguish
between bacteria that are planktonic and bacteria that are associated with the urothelial
cell.
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Table 4- Antibiotic Protection Assay Practice Urine Results

Culture results for the antibiotic protection assay for practice urines 7-16. The –
designates a negative or No Growth result of the urine in that arm of the assay. The
number in front of the organism represents the number of colony forming units
(CFU)/mL of urine for which that organism was present.
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Antibiotic Protection Assay In Detection of Intracellular Bacteria
In the six of 10 practice urines that grew bacterial species, I was able to
distinguish between the bacterial species that were planktonic and those that were
associated with shed urothelial cells. However, from these data, I was unable to
distinguish between bacteria that were attached to urothelial cells and those that were
intracellular. But, a proof of principle assay had not been performed to determine whether
this protocol could detect intracellular bacteria. Therefore, I grew immortalized urothelial
cells and infected them with UPEC, known to be taken up intracellularly by these cells
(Hunstad & Justice, 2010) and then ran the cells with UPEC through the Antibiotic
Protection Assay Arm. If the assay were detecting intracellular bacteria in urothelial cells,
then I would detect UPEC in the antibiotic treatment branch of the assay (Figure 3).
In both instances (Run 1 and Run 2), the Antibiotic Protection Assay Arm did not
detect intracellular UPEC in the immortalized human urothelial cells (Table 5).
However, the Human Urothelial Cell/UPEC Infection Assay arm for Run 1 and Run 2
found an average intracellular count of 330 CFU/mL and 220 CFU/mL of UPEC per
well, respectively. These data suggest that the current Antibiotic Protection Assay is
unable to detect intracellular bacteria.
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Table 5- Human Urothelial Cell/UPEC Infection Assay Results

Summary of the two runs of the proof of principle Human Urothelial Cell/UPEC
Infections Assay. The NG designates a negative or No Growth result for that condition.
The number designates the amount of cells per well cultured in that condition.
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Adherent vs. Intracellular Bacterial Populations
In order to further differentiate between bacterial populations that either adhere to
the urothelial cell surface or are taken up intracellularly, a total of four urine specimens
were placed through both the antibiotic protection and tissue culture adherence assay
arms of the protocol. The antibiotic protection assay is able to distinguish between
bacteria that are planktonic and bacteria that are associated with the urothelial cells
(Figure 3). The tissue-culture adherence assay arm is designed to further characterize the
bacterial populations that associate with the cells into bacteria that adhere to the cell
surface and the bacteria that are taken up intracellularly (Figure 5).
In the antibiotic protection assay arm, bacteria were detected in all four urine
specimens in the no antibiotic treatment arm (Table 6). All bacterial species detected in
the four urines were also detected in the EQUC control; however, they were detected in
two-three logs lower CFU counts. These data suggest that the bacterial species in the no
antibiotic treatment arm are associated with the shed urothelial cells and are not
planktonic. In the tissue-culture adherence assay, two of the four urine specimens in the
no antibiotic arm were not plated for culture (Table 6). This was due to the fact that the
pH indicator in the tissue culture media had changed, indicating a large amount of cell
debris being present in the wells.
In all four specimens, there was no detection of intracellular bacteria in the
antibiotic protection assay. However, with the tissue-culture adherence assay, bacteria
were cultured from the antibiotic condition in two of the four urine specimens, suggesting
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that the bacteria may have been intracellular (Table 6). To confirm that these
organisms were intracellular, antibiotic sensitivities should have been performed.
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Table 6-Antibiotic Protection and Tissue-Culture Adherence Results

Summary of culture results for practice urines 17-20 using both the antibiotic protection
and tissue-culture adherence assays. The None represents no bacteria were grown in that
culture condition in the assay. The N/A designates the culture was not performed due to
overgrowth of bacteria in the tissue-culture adherence assay. Every practice urine had an
EQUC control culture performed.

CHAPTER FOUR
DISCUSSION
The data presented here support the existence of the female urinary microbiota
and further demonstrate differences in the female urinary microbiota in individuals with
and without OAB.
One diagnostic criterion for women who suffer from OAB is a negative standard
urine culture. The implication of the negative standard culture is that the individual does
not suffer from a clinically relevant urinary tract infection and that the symptoms are not
caused by a bacterium (Haylen et al., 2010). However, recent work done by others and
our group support the hypothesis that standard urine culture is not effective in detecting
most of the bacterial taxa present in urine (Khasriya et al., 2013, Hilt et al., 2014).
Khasriya and colleagues (2013) compared standard cultures with cultures of centrifuged
urinary sediment from MV samples from men and women. They were able to culture a
large number of undetected bacteria in the urinary sediment compared to the standard
culture (Khasriya et al., 2013). Our group demonstrated in our recent publication and
here with this work that the standard urine culture had a false-negative rate of ~90%
(Table 1). It is clear that the standard urine culture with a threshold of 105 CFU and
incubation in aerobic conditions for 24 hours is not sufficient for complete and accurate
diagnosis, because it cannot culture a large portion of urinary bacteria. All the evidence
suggests that many culture-negative standard urine cultures are not actually culture52
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negative and demonstrates the need to reevaluate the standard urine culture technique
and to expand it to help women suffering from lower urinary tract disorders other than
UTI.
Our group is not the first to use an expanded culture condition to suggest the reevaluation of the standard urine culture technique. As mentioned in the literature review,
Dr. Rosalind Maskell plated SPA samples on various agar plates and incubated the plates
in a variety of conditions for a longer period of time, a protocol similar to our EQUC
protocol. She was able to culture organisms including Gardnerella vaginalis,
Lactobacillus spp., and fastidious Streptococci (Maskell, 2010). Although specific
species are not mentioned in her text, we found Gardnerella a lot of Lactobacillus and
Streptococcus species in the female urinary microbiota.
The female urinary microbiota in women with OAB are different from the
microbiota of women without OAB. Several bacterial genera were more frequently
cultured from the urine of women with OAB, including Actinobaculum, Actinomyces,
Aerococcus, and Oligella. Interestingly, many of these genera contain emerging
uropathogens, including Actinobaculum schaali, Aerococcus urinae, and Oligella
urethralis (Bank et al., 2010, Zimmermann et al., 2012, Dabkowski et al., 2013,
Rasmussen, 2013), which also were seen more frequently in the urinary microbiota of
women with OAB. Whether these bacteria contribute to OAB is unknown at this time and
requires further research.
Another interesting bacterial species that was more frequently cultured in the
OAB cohort than the non-OAB cohort was Gardnerella vaginalis (Figure 9). This
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bacterium is a facultative anaerobe isolated from the vaginal tract and known to be a
biomarker of the vaginal dysbiosis called bacterial vaginosis (Liu et al., 2013). At this
time, it is not known if the G. vaginalis isolates from the OAB cohort are pathogenic, but
it has been shown previously that G. vaginalis can be cultured from the vaginal tracts of
women with and without bacterial vaginosis (Hyman et al., 2005, Harwich et al., 2010).
More research must be performed to determine if G. vaginalis isolates from both the
OAB and non-OAB cohorts are either pathogenic or symbiotic strains of G. vaginalis.
Intriguingly, the genus Lactobacillus was cultured frequently in both the OAB
and non-OAB cohorts. The bacteria in this genus are lactic acid-producing, facultative
anaerobic bacteria known to play protective roles in the vaginal tract by decreasing pH
and producing various bacteriostatic/cidal compounds (Redondo-Lopez et al., 1990,
Kaewsrichan et al., 2006). However, the Lactobacillus species isolated more frequently
from either cohort was different. L. gasseri was cultured more frequently from the OAB
cohort and L. crispatus was cultured more frequently from the non-OAB cohort (Figure
9). At this time, more research must be performed to determine if this difference is a
consequence of OAB or whether it contributes to OAB symptoms. Stapleton and
colleagues (2011) showed that L. crispatus could be used as a probiotic for recurrent UTI
suggesting that it could play protective role in the female urinary microbiota (Stapleton et
al., 2011).
Finally, these data demonstrate that live culture results match that of sequencing
results (Figure 10). 16S rRNA gene sequencing gives broad view of the urinary bacterial
communities, while culturing live bacteria provides a more focused view.
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The evidence for urinary microbiota is compelling, but whether these bacteria
associate with the bladder urothelium remains uncertain. Bacterial species that associate
with the urothelium are of particular interest because they are more likely to play a role in
OAB symptoms. The bacteria present in the urinary microbiota could associate with the
bladder urothelium in two ways: either (1) by adherence to the surface of the urothelial
cells or (2) by invasion of the urothelial cell. The possibility also exists that some urinary
bacteria are planktonic and do not associate with the urothelium. Such bacteria could
influence the urothelium via secreted products.
There are two methods one could use to identify bacterial species of the urinary
microbiota that associate with the urothelium. The first is to go straight to the source and
culture bladder biopsy tissue; however, this method is invasive and it is difficult to obtain
samples on a regular basis. The second method is to examine bacterial communities
associated with shed urothelial cells in urine (Horsley et al., 2013, Khasriya et al., 2013).
The first method, culture of bladder tissue biopsy, provided some evidence that
the urinary microbiota (or some bacteria in the urinary microbiota) associate with the
human urothelium. I obtained and cultured four sets of bladder biopsy tissue with urine
samples. I was unable to culture any bacteria in the first three samples, including the
urines. However, the bladder tissue biopsies and the urine samples of the fourth patient
yielded similar bacteria (Table 1). Both the urine specimens (TUC and SPA) had large
amounts of Klebsiella pneumoniae and Staphylococcus aureus. A smaller amount of both
organisms were cultured in the bladder biopsy tissue. I do not believe that this is an
artifact of the urine because each tissue is washed twice with saline before being ground
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for culture (as described in Methods and Materials). Other organisms were found in the
bladder biopsy tissue but not in the urine specimens. This is most likely due to
overgrowth of K. pneumoniae and S. aureus. Further work needs to be done to determine
if these bacteria are truly associated with urothelial cells. If so, then one could investigate
this interaction, its effect upon the urothelial cells, and whether any of those effects lead
to OAB symptoms.
Culture of bladder biopsy tissue can provide an accurate picture of the bacteria
that may be associated with the urothelium, but it is an invasive procedure and thus it can
be a challenge to obtain samples. Therefore, to make more rapid scientific progress, it is
important to use another method to identify the bacterial species in the urinary microbiota
that associate with the urothelium. A less invasive approach is to examine shed urothelial
cells in urine (Horsley et al., 2013, Khasriya et al., 2013).
Thus, I developed and attempted to optimize a protocol for future use to
distinguish between the bacterial populations (planktonic, adherent, intracellular) of the
urinary microbiota. The protocol combined three different assays. The first assay was
filtration of the urine to distinguish between planktonic and associated bacteria (Figure
2), the second an antibiotic protection assay to distinguish between planktonic, adherent
and intracellular bacteria (Figure 3), and the third was a tissue-culture adherence assay to
aid in distinguishing between adherent and intracellular bacteria (Figure 5).
The antibiotic protection assay arm of the protocol was able to differentiate
between the planktonic bacteria population and the bacterial populations that associate
with the shed human urothelial cells. In the antibiotic protection assay arm, bacteria were
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detected in some practice urine specimens in the no antibiotic treatment arm (Table 4,
Table 6). All bacterial species detected in the urines were also detected in the EQUC
control; however, they were detected at two-three logs lower CFU counts. These data
suggest that the bacterial species in the no antibiotic treatment arm are associated with the
shed urothelial cells and are not planktonic.
The antibiotic protection assay arm alone could not distinguish between bacteria
that adhere to the urothelial cell surface and intracellular bacteria. In the proof of
principle human urothelial cell/ UPEC infection assay, it was shown that the antibiotic
protection assay could not detect intracellular UPEC in the immortalized human
urothelial cells (Table 5). A modification to this protocol for the future would be to
handle the cells with more care. In addition, it is unknown if adding trypsin in the proof
of principle assay is harmful to the bacterial populations associated with the urothelial
cells. In the control arm of the human urothelial cell/ UPEC infection assay, the cells
were not treated with trypsin (Figure 4). Future control experiments would need to be
performed to determine if trypsin has any effect.
However, this protocol was designed to use multiple assay/arms to obtain a more
complete picture of the different bacterial communities that may associate with the shed
urothelial cells. Some evidence that suggests the tissue-culture adherence arm could help
further distinguish the associated bacterial population into bacteria that are adherent to
the cell surface and intracellular bacteria. In the tissue-culture adherence assay, Dr.
Meghan Pearce was able to detect several bacterial species in the antibiotic treatment
branch that were not detected in the no-antibiotic treatment branch of two urine
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specimens (Practice Urines 18 and 19) (Table 6). These data suggest that these
bacterial species were intracellular.
Overall, these data demonstrate that these two assays complement one another.
The results of the antibiotic protection assay show that it can distinguish between bacteria
that are planktonic and bacteria that are associated with shed urothelial cells. The results
of the tissue-culture adherence assay show that it can take the distinction one step further
and thus distinguish between bacteria that may be adherent and bacteria that may be
intracellular.
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